MiNK Therapeutics (INKT) Stock Chart & Stock Price History $20.31 -2.94 (-12.65%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$20.82 +0.52 (+2.54%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MiNK Therapeutics Stock Price Performance The MiNK Therapeutics (INKT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 130.80%, with a year-to-date return of 191.43%. In the past month, the stock has increased 179.75%, reflecting recent market activity. As of the latest close, MiNK Therapeutics traded at $20.31 with a market cap of $81.04 million and volume of 677,478 shares. Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-27.49%1 Month Performance+179.75%3 Month Performance+166.19%Year-To-Date Performance+191.43%1 Year Performance+130.80% INKT Stock Chart for Sunday, July, 20, 2025 INKT Chart by TradingView MiNK Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025$23.25$20.31-12.65%$24.00$20.14677,478 shs$81.04 million07/17/2025$23.11$23.25+0.61%$30.30$23.201.86 million shs$92.67 million07/16/2025$28.01$23.11-17.49%$30.64$23.11877,142 shs$92.21 million07/15/2025$40.61$28.01-31.03%$34.50$27.521.47 million shs$111.65 million07/14/2025$64.17$40.61-36.71%$52.50$33.625.03 million shs$161.87 million07/11/2025$7.73$64.17+730.14%$76.00$20.2047.69 million shs$255.78 million07/10/2025$7.63$7.73+1.38%$7.80$7.522,666 shs$30.84 million07/09/2025$7.20$7.63+5.90%$7.88$7.282,822 shs$30.42 million07/08/2025$7.28$7.20-1.03%$7.50$7.201,955 shs$28.73 million07/07/2025$6.87$7.28+5.88%$7.52$7.012,370 shs$29.03 million Get the Latest News and Ratings for INKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025$6.87$6.87$7.55$6.803,359 shs$27.39 million07/03/2025$7.28$6.87-5.55%$7.55$6.803,359 shs$27.42 million07/02/2025$7.43$7.28-2.02%$7.17$7.171,376 shs$29.03 million07/01/2025$7.34$7.43+1.16%$7.51$7.223,107 shs$29.63 million06/30/2025$6.98$7.34+5.16%$7.39$6.912,997 shs$29.29 million06/27/2025$7.48$6.98-6.62%$7.45$6.983,474 shs$27.85 million06/26/2025$7.59$7.48-1.52%$7.45$7.351,571 shs$29.83 million06/25/2025$7.30$7.59+3.97%$8.38$6.98253,854 shs$30.25 million06/24/2025$7.48$7.30-2.41%$7.45$7.303,438 shs$29.13 million06/23/2025$7.26$7.48+3.03%$7.59$7.481,062 shs$29.85 million06/20/2025$7.43$7.26-2.29%$7.34$7.113,279 shs$28.94 million06/19/2025$7.43$7.43$7.44$7.431,007 shs$29.65 million Related Companies Enliven Therapeutics Stock Chart Structure Therapeutics Stock Chart Ardelyx Stock Chart Pharvaris Stock Chart Collegium Pharmaceutical Stock Chart Akebia Therapeutics Stock Chart Praxis Precision Medicines Stock Chart Amphastar Pharmaceuticals Stock Chart LENZ Therapeutics Stock Chart Cidara Therapeutics Stock Chart Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INKT) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersCongress Is Talking Crypto. Here’s What It Means for You …Congress is deep into “Crypto Week” — with new bills that could finally bring clarity to digital assets. Cr...Weiss Ratings | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
